Published

Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Translational behavioral medicine
Date: 2024-11-25
Source: PubMed
DOI: 10.1093/tbm/ibae053
PubMed: 39419768

Authors

Adams DR Allen H Nicol GE Cabassa LJ

Watch author

Derived topics and classifications

psilocybin Depression PTSD Addiction Mechanism of Action Clinical Trial Veterans Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 3 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico2026-06-17 Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression2026-03-01 Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.2024-11-25

Related papers

Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.Frontiers in neuroscience · 2026-01-01 Should addiction researchers be interested in psychedelic science?Drug and Alcohol Review · 2017-04-10 Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord InjuryClinicalTrials.gov · 2026-08-10 Psilocybin as a Treatment for Chronic Pain in SmokersClinicalTrials.gov · 2026-08-03 A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-07-23